We believe our commitment to the best corporate governance practices helps us to ensure the business sustainability and to serve the interests of all RD Saúde’s stakeholders: customers, investors, suppliers, employees, community, government, trade unions and associations, among others.
We maintain an ethical and strong relationship with these stakeholders, ensuring that everyone has access to the necessary information and is treated fairly and consistently.
Our Bylaws also establish that decisions taken by shareholders and administrators should always consider the short and long-term interests of RD Saúde and its shareholders, as well as the short and long-term economic, social, environmental and legal effects on our professionals, contractors, suppliers, consumers and creditors of the company and its subsidiaries, in addition to the communities where we operate.
Finance Committee
Led by board member Eugênio De Zagottis and composed of board members Marcilio D´Amico Pousada and Plínio Musseti, its mission is to advise on strategic issues for the financial health of the business.
Fiscal Council
RD Saúde has a Fiscal Council in place at the request of its own Management. Members are elected at the Annual General Meeting, and the Fiscal Council currently consists of four standing members and an equal number of alternate members.
The standing members are: Adeildo Paulino, Gilberto Lerio, Guilherme Bottrel Pereira, and Paulo Sérgio Buzaid Tohmé.
The alternate members are: Flávio da Silveira dos Anjos, Jayme Sanches Neto, Mário Antonio Luiz Corrêa, and Vivian do Valle Souza Leão.
Board of Directors
Our Board has 13 members, of which 6 are independent, and 3 are women. The Board's mission is to protect and enhance RD Saúde's assets, contributing with guidelines that make the business sustainable and acting as a guardian of the company's essence, culture, and interests of all stakeholders.
The members are: Marcilio D’Amico Pousada (Chairman of the Board of Directors); Antonio Carlos Pipponzi (Member); André Pires Oliveira Dias (Member); Cristiana Almeida Pipponzi (Member); Eugênio de Zagottis (Member); Paulo Sérgio Coutinho Galvão Filho (Member); Renato Pires Oliveira Dias (Member); Eliézer Silva (Independent Member); Flávia Maria Bittencourt (Independent Member); Marco Ambrogio Crespi Bonomi (Independent Member); Philipp Paul Marie Povel (Independent Member); Plínio Villares Musetti (Independent Member); and Sylvia de Souza Leão (Independent Member).
Management
The group responsible for executive management and strategy execution is elected by the Board of Directors. The terms of office are two years, with reelection permitted.
Currently, the Executive Board is led by the Chief Executive Officer (CEO) and is composed of vice-presidencies dedicated to key themes of our strategy. All members of the Management undergo annual evaluation processes conducted by external consultants and by the People Committee of the Board of Directors.
The members of the Executive Board are: Renato Cepollina Raduan (Chief Executive Officer (CEO); Marcello De Zagottis (Chief Operating Officer (COO); Antonio Carlos Coelho (Chief Financial and Administrative Officer); Bruno Wright Pipponzi (Vice President of Healthcare Businesses); Erika Petri (Vice President of People, Culture and Sustainability); Flávio de Moraes Correira (Investor Relations Officer); Fernando Kozel Varela (Vice President of Digital Transformation); Juliana Lopes Marques Paixão (Vice President of Commercial and Marketing); Melissa Teixeira Cabral (Vice President of Pharmacy Operations); and João José de Barros Neto (Vice President of Supply Chain).
Audit Committee
Advisory body with permanent operation and non-statutory nature. It is composed of 4 members: Pedro Augusto de Melo (leader), Marcilio D´Amico Pousada (chairman of the Board of Directors), Plínio Mussetti (independent) and Pedro Zan (expert in corporate accounting). This committee is responsible, among other things, for analyzing the financial statements and supervising the areas of risk management, internal audit, compliance, internal controls, data management and cyber security.
Strategy Committee
Composed of the 13 members of the Board of Directors, its mission is to develop and propose policies related to business strategy, improvement of operations, digital transformation and transformation of a company focused on its customers.
Sustainability Committee
Led by board member Cristiana Pipponzi and composed of board members Marcilio D´Amico Pousada and Sylvia Leão, its role is to develop and propose to the Board of Directors guidelines, commitments and actions linked to the environmental, social and governance (ESG) agenda, in addition to supervising the work of RD Saúde's Sustainability Department.
Expansion Committee
Its role is to advise the Company's Management in developing expansion policies and strategies in current and new markets, defining the location of new pharmacies and closing active ones, and in organizing the acquisition strategy in order to achieve development and expansion objectives. It's led by board member Antonio Carlos Pipponzi and composed of board members Marcilio D´Amico Pousada.
People and Governance Committee
Led by independent board member Sylvia Leão, and composed of board members Antonio Carlos Pipponzi, Marcílio D´Amico Pousada, Marco Bonomi and Eugênio De Zagotis, this committee advises the Board on all matters related to RD Saúde's human capital, including the evaluation, appointment, succession, and compensation of executives, as well as the overall human resources strategy, with a focus on talent attraction and retention.
